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Abstract
Background: Hepatitis B virus (HBV) infection is a problem in several regions of the world with limited
resources. Blood samples dried on filter paper (DBS) have been successfully used to diagnose and monitor several
infectious diseases. In Mexico there is an urgent need for an affordable and easy sampling method for viral load
(VL) testing and monitoring of chronic HBV infection. The purpose of this work was to validate the utility of DBS
samples for monitoring HBV infection in patients from Mexico City.
Methods: Matched samples of plasma and DBS on filter paper from 47 HBV infected patients from the Instituto
Mexicano del Seguro Social (IMSS), were included. To evaluate the DNA stability and purity from DBS stored at
different temperature conditions, samples from ten patients were stored at 4 degree, 25 degree, and 37 degree
C for 7 days. After DBS elution and DNA extraction, the purity of these samples was determined measuring the
O.D. rate 260/280. The DBS utility for molecular studies was assessed with PCR assays to amplify a 322 bp
fragment from the "a" determinant region of the HBV "S" gene. The VL from all samples was determined to
evaluate the correlation between plasma and DBS matched samples.
Results: The quality of the DNA from DBS specimen is not adversely affected by storage at 4 degree, 25 degree
and 37 degree C for up 7 days. Statistical ANOVA analyses did not show any significant difference. The same
amplification efficiency was observed between DNA templates from samples stored at different temperatures.
The Pearson correlation between the VL from DBS and plasma matched samples was 0.93 (p = 0.01). The SD was
1.48 for DBS vs.1.32 for Plasma, and an average of log10 copies/mL of 5.32 vs. 5.53. ANOVA analysis did not show
any statistically significant difference between the analyzed groups (p = 0.92).
Conclusion: The results provide strong evidence that the isolation and quantification of DNA-HBV from DBS is
a viable alternative for patient monitoring, and molecular characterization of the virus variants circulating in
Mexico.
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Background
Blood samples dried on filter paper have been successfully
used to diagnose and monitor several infectious diseases.
The dried blood spots (DBS) have been used to detect
antibodies, and to purify nucleic acids and other mole-
cules. Filter papers were initially used for the screening of
newborn metabolic disorders [1]. Currently, they have
proved useful in detection, quantification and identifica-
tion of a variety of infectious pathogens, including viruses
(HIV and CMV) [2-4], and different parasitic infections
[5]. DBS samples are a simple and inexpensive sampling
method, especially useful for blood collection in resource-
poor settings with limited access to diagnostic facilities.
The main advantage of DBS samples over routine blood
samples is that only a small quantity of blood, typically 50
μl, is required to make one dried blood spot. They are easy
to obtain, stable for long periods of time, and can be
transported to a reference laboratory at minimal cost [6-
8].
Hepatitis B virus (HBV) infection is a problem in several
regions of the world with limited resources. The diagnosis
and monitoring of HBV infection is generally based on the
determination of serologic markers, and viral load quan-
tification; however, molecular characteristics such as gen-
otype and genetic variants are not used routinely.
Based on the complete genome sequences, HBV has been
classified into eight genotypes, A to H [9,10]. In Mexico,
where the incidence of disease is increasing [11], genotype
H is predominant [12,13]. Since it is the most recently
described genotype, information about the genetic char-
acteristics and molecular variants circulating in our coun-
try is limited.
In spite of the urgent need for an affordable and easy sam-
pling method for viral load testing and monitoring of
chronic HBV infection, there is only one report on the role
of DBS in evaluation of patients infected with HBV. In this
study, the viral load was 1 log lower than those detected
in serum samples. However, DNA amplified from these
samples proved to be useful in the identification of spe-
cific mutations in the precore and polymerase motifs [14].
We were interested in validating the use of DBS samples as
an alternative to plasma for monitoring HBV infection
and the potential utility for molecular studies. Our data
support the utility of the DBS sampling for monitoring
HBV infection. Therefore we strongly recommend this
method of specimen collection for HBV infection moni-
toring in low resources countries.
Materials and methods
Patients
This study included 47 hepatitis B surface antigen -posi-
tive (HBsAg) patients from the Instituto Mexicano del Seg-
uro Social (IMSS). Local ethical and scientific committees
of the Institute approved the procedures and the protocol.
Blood samples for the study and basic demographic data
were obtained under informed consent from each subject
(Table 1).
Plasma and DBS samples
Two tubes of EDTA-anticoagulated whole blood and one
tube without anticoagulant were collected by venipunc-
ture from each subject. Plasma aliquots were obtained by
centrifugation of the 8 mL whole blood at 4000 rpm for
20 min. The supernatant was stored at -70 degree C until
use. Replicate sets of DBS samples were prepared drop-
ping 50 μl of whole blood in each circle (5 spots per card)
of the filter paper (SS&S903, Schleicher & Schull). They
were air-dried for 4 h at room temperature and then
placed into zip-locked bag along with silica gel desiccant
sachet, and stored at -20 degree C until processing.
HBV-DNA DBS stability storage at different temperatures
Ten different patient samples were kept at 4, 25 and 37
degree C for 7 days, before storing at -20 degree C until
use. One set of samples was stored since the beginning at
-20 degree C for comparison.
Nucleic acid isolation from dried blood samples and 
plasma, and PCR assay
In order to determine the quality and utility of the DNA
extracted from DBS samples stored at different tempera-
tures, two approaches were used. The DNA quality was
measured by spectrophotometer and the utility of the
sample for molecular analyses was evaluated by PCR
amplification of a fragment from the determinant "a"
region of the genome [13,15].
a) Nucleic acid isolation
For plasma samples, extraction was performed using the
QIAamp®  Ultrasens®  Virus kit (QIAGEN GMBH, Ger-
many), with 100 μl of plasma following the manufac-
turer's instructions. Scissors were used to cut one or two
spots for each sample (50 μl/spot), and the blood was
eluted and the DNA extracted using the QIAamp® DNA
micro kit (QIAGEN GMBH, Germany), following the
manufacturer's instructions. The quality of the extracted
DNA was assessed by spectrophotometry (NanoDrop®
Table 1: Clinical and virological patient data
Patients n = 47
Sex M: F 36:11
Age 35.7 ± 12.9
Plasma viral load 1,280 - 68,000,000
(copies/mL) log10 3.1- 7.8
HBeAg+ 38 (72.2%)
Anti-HBeAg 15 (27.8%)
Anti-HBc 49 (90.7%)Virology Journal 2009, 6:153 http://www.virologyj.com/content/6/1/153
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ND-1000 Spectrophotometer v3.0.1, USA.) and the opti-
cal density (O.D.) 260/280, was calculated.
b) Amplification by PCR
In order to determine the utility of the extracted nucleic
acids from DBS samples for molecular studies, the DNA
extracted was utilized as a template for PCR to amplify a
fragment from the determinant "a" region of the HBV "S"
gene using primers and conditions previously reported
[15]. Sequences of the outer primers and their relative
positions were as follows: HBV1-sense, 5'-CGC TGG ATG
TGT CTG CGG CGT-3', position 371-391, and HBV2-anti-
sense, 5'-CGA ACC ACT GAA CAA ATG GCA CT-3', posi-
tion 682-704. Briefly, 10 μL of DNA extracted from
plasma and DBS samples were mixed with 40 μL of master
mix containing 1 × PCR buffer, 50 pmoles of each primer,
0.2 mM dNTPs, 2.5 mM MgCl2, and 2.5U Taq polymerase
(Amplificasa® BIOGENICA, Mexico). PCR amplification
was performed using HBV1-sense and HBV2- antisense
outer primers as described previously [13]. A 322 bp prod-
uct was visualized by ethidium bromide staining on a 1%
agarose gel.
c) Plasma viral load (VL) quantification
The levels of HBV DNA in 100 μl of plasma were quanti-
fied by using the Amplicor HBV Monitor kit (Roche
Molecular Systems, Inc.) according to the manufacturer's
instructions.
DBS viral load (VL) quantification
The blood was eluted from a single filter spot for each
sample (50 μl). For plasma VL below log 104, two discs
were used. The eluted material was processed using the
QIAamp® DNA micro kit (QIAGEN GMBH, Germany) fol-
lowing the manufacturer's instructions. The final volume
of extracted DNA elution was 50 μL in dH2O HBV Moni-
tor Cobas Amplicor v 1.5 (Roche Diagnostics, New Jersey,
EU). Samples with plasma VL > 106 were diluted 1:100
with saline solution. A 1:1000 dilution was used in sam-
ples with VL > 107.
Statistical analyses
The statistical analyses were performed using SPSS 10.0
version software (SPSS Chicago IL). Pearson correlation
was used to determine the association between VL from
DBS and plasma. The ANOVA analysis was used to evalu-
ate differences between the VL of groups stored at differ-
ent temperatures. Kruskal-Wallis Test was used to evaluate
differences between the O.D. measurements for the DBS
extracted DNA quality.
Results
DBS genomic DNA integrity and storage temperature 
stability studies
To evaluate the utility of the HBV DNA extracted from
DBS to monitor viral load (VL) and perform molecular
analyses, three assays were done with ten different sam-
ples stored for 7 days at 4 degree, 25 degree and 37 degree
C, and compared with samples stored at -20 degree C.
a. DNA quality measurements
The quality of the DNA extracted from the 10 different
samples stored at 4 different temperatures was obtained
by duplicates of O.D. 260/280 measurements. The
ANOVA test (p 0.67) did not show significant difference
between samples. The quality of the DNA extracted from
DBS is not adversely affected by storage at 4 degree C, RT,
and 37 degree C for up 7 days.
b. PCR amplification
To evaluate the efficiency of amplification a PCR product
of 322 bp from the HBV determinant "a" genome was
amplified. Concordance between DBS stored at different
temperatures and plasma samples for HBV-PCR amplifi-
cation was optimal, because all the samples were success-
fully amplified (Fig 1).
c. Correlation between HBV-DNA VL in DBS samples stored at 
different temperatures and frozen plasma
First, the dried whole blood spot stability was evaluated
measuring the VL from samples stored at 4 degree, 25
degree, and 37 degree C. The data (Fig 2) showed no dif-
ference in VL values from matched samples stored at dif-
ferent temperatures compared to the gold standard in
plasma; the 5.32 and 5.53 log differences were not statis-
tically significant by the ANOVA test. The CI 95% for the
gold standard in plasma was (3.1-7.83), for DBS at: -20
Stability of the dried blood samples Figure 1
Stability of the dried blood samples. PCR amplifications 
of HBV DNA from DBS. 1% Agarose gel showing a 322 bp 
fragment of the HBV-"a determinant" amplified from DBS 
samples stored at different temperatures. 1. DNA molecular 
markers; 2 negative control; 3 Plasma at -70 degree C; 4 DBS 
at -20 degree C; 5, DBS at 4 degree C; 6, DBS at 25 degree 
C; 7, DBS at 37 degree C. The arrowhead on the left denotes 
the 322-bp amplified product.Virology Journal 2009, 6:153 http://www.virologyj.com/content/6/1/153
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degree C (3.05-7.57); at 4 degree C (2.91-7.39); at 25
degree C (2.97-7.41) and at 37 degree C (2.67-7.83). The
DBS storage temperature at 4 degree, 25 degree and 37
degree C for up 7 days did not affect the VL measurements.
Correlation between viral load (VL) of plasma and dried 
blood samples
To validate the utility of DBS, VL determination of
matched samples from plasma and DBS was performed.
The average value for VL in plasma was log10 5.48 with a
SD of 1.32, and in DBS was 5.29 with SD of 1.46. The sen-
sitivity of HBV DNA detection in DBS was the same as in
plasma samples (100%). In evaluating the VL only one
disc per sample (50 μl) was used, and plasma value was
obtained from 100 μl, therefore a normalization factor of
2 was used for the final DBS values. In addition, it was
important to use a 1:100 dilution when samples with VL
concentration in plasma was log10 6.1-6.9, because sam-
ples without dilution did not correlate with paired plasma
sample values. In samples with log10 from 6.9 to 7.8, a
1:1000 dilution was used. These modifications allowed us
to obtain a good linear correlation in a log-log plot
between HBV-DNA concentrations in DBS versus plasma
samples (Fig. 3). We also found a high Pearson correlation
coefficient (0.93). This result clearly indicated that DNA
HBV concentration from DBS is highly comparable to
plasma paired values.
Discussion
Traditionally, the monitoring of HBV infection is done by
serological assays involving serum and plasma samples
that require frozen storage conditions. Blood samples
must be processed within 6 hours of collection. If the
assay is not available immediately, the samples must be
frozen at -20 for serum, or -70 degree C for plasma. In
developing countries where cold storage and transporta-
tion present special problems, the use of DBS should be
considered. The introduction of whole blood samples in
filter paper or DBS in clinical samples has improved the
monitoring and sentinel surveillance of various infectious
diseases. Several studies have been done to demonstrate
the efficiency of the method for collection and long term
storage for field samples [3,16-19]. The use of DBS for
monitoring of HIV-1 infection has shown that this sam-
pling method is useful not only for a safe and easy manip-
ulation of a contagious sample, but also for diagnosis and
epidemiologic monitoring of the infection [2,14,20].
In the case of HBV infection, DBS samples have been used
for detection of viral antigens and antibodies [21,22].
Jardi et al, demonstrated the application of DBS samples
for HVB DNA quantification and genetic variant analysis
[14]. They found that sensitivity of HBV DNA quantifica-
tion in DBS samples was 1 log lower than in serum sam-
ples. The detection limit of the DBS assay was 2 × 103
HBV-DNA copies/mL, and only A, D and F genotypes
were assayed. Interestingly, by using the plasma concen-
tration as a reference value to determine if the sample
should be diluted, our results showed a very good correla-
tion between VL of plasma vs. DBS samples. According to
the manufacturer Cobas Amplicor HBV Monitor Roche,
samples with high viral loads, e.g. higher than log10 5.1,
will saturate the amplification system and must be diluted
in order to obtain a correct value. It is recommended to
dilute samples from 1:10, 1:100 and 1:1000 depending
on the result. By using this method, the sensitivity of was
the same for plasma and DBS samples, supporting the use
of these samples for VL determinations and monitoring
infection in countries with low resources.
In Mexico, DBS sampling method is not used for monitor-
ing HBV infection, even though the incidence of this dis-
ease is increasing [11]. We think it is urgent to introduce a
simple and non-costly sampling method in order to
improve the molecular diagnosis and monitoring of HBV
infection and reduce the cost in the management of the
disease. We also found that different storage temperatures
up to 7 days did not affect the quality of the HBV DNA.
The use of these samples is readily applicable in countries
like Mexico, where the cold storage and transportation is
expensive or sometimes unavailable. It is very important
to establish a Reference Center where the samples from all
over the country could be collected and assayed for mon-
itoring infection and perform genetic analyses. Remarka-
bly, samples stored at room temperature (25 degree C) are
an excellent option to perform viral load quantification
Viral Load correlation between DBS and plasma matched  samples at different storage temperatures Figure 2
Viral Load correlation between DBS and plasma 
matched samples at different storage temperatures. 
The VL was assessed by Cobas Monitor Amplicor, and the 
values were transformed to Log10. VL values for plasma sam-
ples from ten different patients (sample ID) stored at -70 
degree C (P), and paired blood spots samples stored at 4 
degree C (D 4), 25 degree C (D 25), 37 degree C (D 37), and 
-20 degree C (D-20) for up to 7 days, and removed to -20 
degree C until analysis.Virology Journal 2009, 6:153 http://www.virologyj.com/content/6/1/153
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and other molecular studies, like PCR amplification to
detect genomic differences in isolates from different
regions. Several investigators have reported the DBS stor-
age at different conditions did not affect significantly the
VL determinations [6-8]. The time of storage is also an
advantage in the use of these samples, because it has been
reported that RNA HIV-1 stored up 28 years did not affect
the VL determinations. It is clear that extrapolations to the
use of DBS are a valuable option.
Conclusion
These results provide strong evidence that the isolation
and quantification of HBV from samples collected on fil-
ter paper is a viable alternative to the routine freezing
method for the transportation of clinical plasma or serum
samples, and to perform monitoring of the virus variants
circulating in Mexico.
List of abbreviations
HBV: hepatitis B virus; DBS: dried blood spots; HBsAg:
Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen;
HBcAg: Hepatitis B core antigen; VL: viral load; IMSS:
Instituto Mexicano del Seguro Social.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
RL participated in the study design and participated in
drafting and discussing the manuscript. AMR, ORM, and
HVS performed the experiments and discussing the man-
uscript. MRT and OM participated in the study design and
discussing the results. RT and CC provided patients and
all participated in drafting and discussing the manuscript.
AG performed the statistic analysis. MTAM participated in
the study design, and in drafting and discussing the man-
uscript. All authors have read and approved the final man-
uscript.
Authors' information
RL. Unidad de Investigacion Medica en Enfermedades
Infecciosas y Parasitarias. Hospital de Pediatria, Centro
Medico Nacional Siglo XXI, Instituto Mexicano del Seguro
Social, Cuauhtemoc 330 Col. Doctores, Delegacion
Cuauhtemoc, Mexico City, MEXICO 06720.
Acknowledgements
We thank Dr Margarita Dehesa Violante and the Blood bank of the CMN 
SXXI, IMSS, for patient inclusion. We thank Dra. Ana M. Cevallos and M. 
Armant for valuable comments and review to the manuscript, and Dr. 
David Sacks for English editing. This work was supported by grant from 
CONACYT-SALUD 2004-001-009. Mexico.
References
1. Guthrie R, Susi A: A simple phenylalanine method for detect-
ing phenylketonuria in large populations of newborn infants.
Pediatrics 1963, 32:338-343.
2. Alvarez-Munoz MT, Zaragoza-Rodriguez S, Rojas-Montes O, Palacios-
Saucedo G, Vazquez-Rosales G, Gomez-Delgado A, et al.: High cor-
relation of human immunodeficiency virus type-1 viral load
measured in dried-blood spot samples and in plasma under
different storage conditions.  Arch Med Res 2005, 36:382-386.
3. Cassol S, Salas T, Gill MJ, Montpetit M, Rudnik J, Sy CT, et al.: Stabil-
ity of dried blood spot specimens for detection of human
immunodeficiency virus DNA by polymerase chain reaction.
J Clin Microbiol 1992, 30:3039-3042.
4. Beck IA, Drennan KD, Melvin AJ, Mohan KM, Herz AM, Alarcon J, et
al.: Simple, sensitive, and specific detection of human immu-
nodeficiency virus type 1 subtype B DNA in dried blood sam-
ples for diagnosis in infants in the field.  J Clin Microbiol 2001,
39:29-33.
5. Maeno Y, Nakazawa S, Dao lD, Yamamoto N, Giang ND, Van HT, et
al.: A dried blood sample on filter paper is suitable for detect-
ing Plasmodium falciparum gametocytes by reverse tran-
scription polymerase chain reaction.  Acta Trop 2008,
107:121-127.
6. Karlsson H, Guthenberg C, von DU, Kristenssson K: Extraction of
RNA from dried blood on filter papers after long-term stor-
age.  Clin Chem 2003, 49:979-981.
7. Zhang YH, McCabe ER: RNA analysis from newborn screening
dried blood specimens.  Hum Genet 1992, 89:311-314.
8. Matsubara Y, Ikeda H, Endo H, Narisawa K: Dried blood spot on
filter paper as a source of mRNA.  Nucleic Acids Res 1992,
20:1998.
9. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO: Genotype H:
a new Amerindian genotype of hepatitis B virus revealed in
Central America.  J Gen Virol 2002, 83:2059-2073.
10. Norder H, Courouce AM, Magnius LO: Complete genomes, phy-
logenetic relatedness, and structural proteins of six strains of
the hepatitis B virus, four of which represent two new geno-
types.  Virology 1994, 198:489-503.
11. Valdespino JL, Conde-Gonzalez CJ, Olaiz-Fernandez G, Palma O,
Sepulveda J: Prevalencia en Mexico de la infeccion y el estado
de portador de la hepatitis B en adultos.  Salud Publica de Mexico
2007, 49:s404-s411.
12. Alvarado-Esquivel C, Sablon E, Conde-Gonzalez CJ, Juarez-Figueroa
L, Ruiz-Maya L, Aguilar-Benavides S: Molecular analysis of hepati-
tis B virus isolates in Mexico: predominant circulation of hep-
Log-log10 graph showing the linear regression comparing VL  data obtained from 47 matched samples of DBS vs. Plasma Figure 3
Log-log10 graph showing the linear regression com-
paring VL data obtained from 47 matched samples of 
DBS vs. Plasma. Log10 measurements of the HBV DNA in 
DBS and Plasma samples, assessed by Cobas Monitor Ampli-
cor. The values for the DBS are plotted against the values for 
the matched plasma samples. The linear correlation between 
the two samples is shown (R2 = 0.86). The Pearson correla-
tion coefficient was 0.93.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Virology Journal 2009, 6:153 http://www.virologyj.com/content/6/1/153
Page 6 of 6
(page number not for citation purposes)
atitis B virus genotype H.  World J Gastroenterol 2006,
12:6540-6545.
13. Ruiz-Tachiquin ME, Valdez-Salazar HA, Juarez-Barreto V, Dehesa-
Violante M, Torres J, Munoz-Hernandez O, et al.: Molecular analy-
sis of hepatitis B virus "a" determinant in asymptomatic and
symptomatic Mexican carriers.  Virol J 2007, 4:6.
14. Jardi R, Rodriguez-Frias F, Buti M, Schaper M, Valdes A, Martinez M,
et al.: Usefulness of dried blood samples for quantification and
molecular characterization of HBV-DNA.  Hepatology 2004,
40:133-139.
15. Nainan OV, Khristova ML, Byun K, Xia G, Taylor PE, Stevens CE, et
al.: Genetic variation of hepatitis B surface antigen coding
region among infants with chronic hepatitis B virus infection.
J Med Virol 2002, 68:319-327.
16. Barbi M, Binda S, Caroppo S: Diagnosis of congenital CMV infec-
tion via dried blood spots.  Rev Med Virol 2006, 16:385-392.
17. Behets F, Kashamuka M, Pappaioanou M, Green TA, Ryder RW, Bat-
ter V, et al.: Stability of human immunodeficiency virus type 1
antibodies in whole blood dried on filter paper and stored
under various tropical conditions in Kinshasa, Zaire.  J Clin
Microbiol 1992, 30:1179-1182.
18. Sjoholm MI, Dillner J, Carlson J: Assessing quality and functional-
ity of DNA from fresh and archival dried blood spots and rec-
ommendations for quality control guidelines.  Clin Chem 2007,
53:1401-1407.
19. Youngpairoj AS, Masciotra S, Garrido C, Zahonero N, de MC, Garcia-
Lerma JG: HIV-1 drug resistance genotyping from dried blood
spots stored for 1 year at 4 degrees C.  J Antimicrob Chemother
2008, 61:1217-1220.
20. Mwaba P, Cassol S, Nunn A, Pilon R, Chintu C, Janes M, et al.: Whole
blood versus plasma spots for measurement of HIV-1 viral
load in HIV-infected African patients.  Lancet 2003,
362:2067-2068.
21. Das PC, de Vries AH, McShine RL, Sibinga CT: Dried sera for con-
firming blood-borne virus infections (HCV, HTLV-I, HIV &
HBsAg).  Transfus Med 1996, 6:319-323.
22. Tappin DM, Greer K, Cameron S, Kennedy R, Brown AJ, Girdwood
RW: Maternal antibody to hepatitis B core antigen detected
in dried neonatal blood spot samples.  Epidemiol Infect 1998,
121:387-390.